SPSB1 Promotes Subcutaneous Adipose Hyperplasia in Facial Port‐Wine Stains by Controlling HDAC1 Degradation and Stability Through Two Distinct Proteolytic Pathways
Source abstract
Abstract
ABSTRACT Facial port‐wine stains (PWS) are often complicated by subcutaneous adipose hyperplasia, yet the underlying cellular and molecular mechanisms remain unclear. Here, using single‐cell RNA sequencing of facial adipose tissues, we identified a distinct subpopulation of adipose stem and progenitor cells that expressed high levels of SPSB1 in hypertrophic PWS. SPSB1 expression was transcriptionally upregulated by FOSL1. Functional assays revealed that SPSB1 potently promoted adipogenesis both in vitro and in vivo. Mechanistically, SPSB1, acting as an adapter for the Cullin‐RING E3 ligase complex, directly interacted with HDAC1. It specifically mediated K48‐ and K29‐linked polyubiquitination of HDAC1 at lysine residues 89 and 361, respectively, thereby targeting HDAC1 for degradation via both the ubiquitin‐proteasome and autophagy‐lysosome pathways. The degradation of HDAC1 increased chromatin accessibility of key adipogenic genes and promoted their expression. Furthermore, HDAC1 downregulation relieved its transcriptional repression on the SPSB1 promoter, establishing a positive feedback loop that perpetuated the pro‐adipogenic signal. Collectively, our findings delineated a novel SPSB1‐HDAC1 regulatory axis that drove pathological adipose hyperplasia in facial PWS, highlighting SPSB1 and HDAC1 as potential therapeutic targets for this condition.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Adipokines, Inflammation, and Metabolic Diseases · Hair Growth and Disorders · Skin Protection and Aging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Plastic & Reconstructive Medicine Shanghai Ninth People's Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
Department of Laser and Aesthetic Medicine Shanghai Ninth People's Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
References (61)
Show source-provided references
1. 10.1136/jcp‐2024‐20962510.1136/jcp‐2024‐209625 ↗
2. Imaging and Pathological Characteristics of Port‐Wine Stain Patients with Tissue Hypertrophy before Laser Therapy: Retrospective Data10.1089/photob.2020.4982 ↗
3. 10.1038/s41421‐022‐00466‐310.1038/s41421‐022‐00466‐3 ↗
4. 10.1038/s41421‐022‐00402‐510.1038/s41421‐022‐00402‐5 ↗
5. 10.1038/s41467‐025‐62361‐110.1038/s41467‐025‐62361‐1 ↗
6. 10.1016/j.lfs.2025.12341710.1016/j.lfs.2025.123417 ↗
7. 10.1038/s41588‐025‐02300‐410.1038/s41588‐025‐02300‐4 ↗
8. 10.1038/s42255‐025‐01378‐810.1038/s42255‐025‐01378‐8 ↗
9. 10.1002/mco2.7052810.1002/mco2.70528 ↗
10. 10.1186/s43556‐025‐00389‐x10.1186/s43556‐025‐00389‐x ↗
11. HERP Constrains White Adipose Expansion and Inflammation by STEAP4 Stabilization10.1038/s41418-025-01608-2 ↗
12. 10.1038/s41392‐024‐01930‐010.1038/s41392‐024‐01930‐0 ↗
13. 10.1007/s00018‐022‐04511‐y10.1007/s00018‐022‐04511‐y ↗
14. 10.1038/nrm154710.1038/nrm1547 ↗
15. 10.1074/jbc.M41389720010.1074/jbc.M413897200 ↗
16. 10.1101/gad.125240410.1101/gad.1252404 ↗
17. 10.1186/1747‐1028‐3‐710.1186/1747‐1028‐3‐7 ↗
18. 10.3389/fimmu.2019.0312110.3389/fimmu.2019.03121 ↗
19. 10.1038/cr.2017.710.1038/cr.2017.7 ↗
20. 10.1016/j.tcb.2020.09.00710.1016/j.tcb.2020.09.007 ↗
21. 10.1038/s41586‐018‐0226‐810.1038/s41586‐018‐0226‐8 ↗
22. Identification of a Mesenchymal Progenitor Cell Hierarchy in Adipose Tissue10.1126/science.aav2501 ↗
23. 10.1016/j.molcel.2017.04.01010.1016/j.molcel.2017.04.010 ↗
24. Adipose Tissue Development Relies on Coordinated Extracellular Matrix Remodeling, Angiogenesis, and Adipogenesis10.3390/biomedicines10092227 ↗
25. 10.1167/iovs.11‐755010.1167/iovs.11‐7550 ↗
26. 10.1101/gad.350759.12310.1101/gad.350759.123 ↗
27. 10.1126/science.aax024910.1126/science.aax0249 ↗
28. 10.1038/nmeth.446310.1038/nmeth.4463 ↗
29. 10.1186/s13005‐024‐00412‐610.1186/s13005‐024‐00412‐6 ↗
30. An Immortalized Adipose‐derived Stem Cells Line from the PIK3CA‐related Overgrowth Spectrum: Unveiling Novel Therapeutic Targets10.1016/j.bbrep.2024.101869 ↗
31. 10.1016/j.metabol.2025.15628810.1016/j.metabol.2025.156288 ↗
32. 10.1186/s13287‐024‐03835‐910.1186/s13287‐024‐03835‐9 ↗
33. 10.1080/21623945.2021.191886310.1080/21623945.2021.1918863 ↗
34. 10.1038/s41580‐018‐0001‐610.1038/s41580‐018‐0001‐6 ↗
35. 10.1242/jcs.114.13.249110.1242/jcs.114.13.2491 ↗
36. Epigenetic Regulation in Ischemic Neuroprotection: The Dual Role of HDACs and HATs in Neuroinflammation and Recovery10.3390/antiox14081015 ↗
37. 10.1038/s12276‐025‐01566‐210.1038/s12276‐025‐01566‐2 ↗
38. 10.1016/j.drup.2024.10115810.1016/j.drup.2024.101158 ↗
39. 10.1007/s10565‐021‐09608‐x10.1007/s10565‐021‐09608‐x ↗
40. 10.1016/j.jare.2024.12.04610.1016/j.jare.2024.12.046 ↗
41. 10.1093/nar/gkac02710.1093/nar/gkac027 ↗
42. 10.1016/j.redox.2019.10141410.1016/j.redox.2019.101414 ↗
43. 10.1371/journal.pgen.100923310.1371/journal.pgen.1009233 ↗
44. 10.1038/cddis.2013.13010.1038/cddis.2013.130 ↗
45. PJA2 Suppresses Colorectal Cancer Progression by Controlling HDAC2 Degradation and Stability10.1002/advs.202401964 ↗
46. 10.1016/j.bbrc.2025.15314710.1016/j.bbrc.2025.153147 ↗
47. 10.1016/j.bbrc.2019.01.08810.1016/j.bbrc.2019.01.088 ↗
48. 10.1186/s12964‐018‐0223‐410.1186/s12964‐018‐0223‐4 ↗
49. Adipose Tissue Hyperplasia and Hypertrophy in Common and Syndromic Obesity‐The Case of BBS Obesity10.3390/nu15153445 ↗
50. 10.1186/s12915‐025‐02405‐610.1186/s12915‐025‐02405‐6 ↗
51. 10.1002/jcsm.1325210.1002/jcsm.13252 ↗
52. 10.1038/s43587‐025‐00952‐910.1038/s43587‐025‐00952‐9 ↗
53. 10.1111/obr.1372410.1111/obr.13724 ↗
54. 10.1177/074873041987803610.1177/0748730419878036 ↗
55. 10.1038/ncomms1049210.1038/ncomms10492 ↗
56. 10.7150/thno.8630710.7150/thno.86307 ↗
57. 10.1016/j.bbalip.2021.15904510.1016/j.bbalip.2021.159045 ↗
58. 10.1038/emboj.2010.13610.1038/emboj.2010.136 ↗
59. 10.1016/j.freeradbiomed.2025.08.00110.1016/j.freeradbiomed.2025.08.001 ↗
60. 10.1038/s41467‐024‐49105‐310.1038/s41467‐024‐49105‐3 ↗
61. PIK3CA Mutations Downregulate PPT1 to Promote Adipogenesis by Suppressing P300 Depalmitoylation and Phase Separation10.1002/advs.202523139 ↗